PL3882249T3
Deuterated derivatives of ruxolitinib
Abstract
This record has no abstract on file.
Term
6.7 yearsto projected expiry
Projected expiry 14 June 2033, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
51 members in 19 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 201261660428 | United States of America | P | |
| 201261678795 | United States of America | P |
Members51
| Document | Office | Kind | |
|---|---|---|---|
| CA2876306A1 | Canada | A1 | |
| WO2013188783A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2013188783A8 | World Intellectual Property Organization (WIPO) | A8 | |
| AU2013274030A1 | Australia | A1 | |
| MX2014015185A | Mexico | A | |
| EP2861600A1 | European Patent Office (EPO) | A1 | |
| US2015197525A1 | United States of America | A1 | |
| US2015197525A1 | United States of America | A1 | |
| EA201492287A1 | Eurasian Patent Organization (EAPO) | A1 | |
| US2015239896A1 | United States of America | A1 | |
| US2015239896A1 | United States of America | A1 | |
| IN10670DEN2014A | India | A | |
| US9249149B2 | United States of America | B2 | |
| US9249149B2 | United States of America | B2 | |
| AU2013274030B2 | Australia | B2 | |
| AU2016238877A1 | Australia | A1 | |
| BR112014031204A2 | Brazil | A2 | |
| US2017239254A1 | United States of America | A1 | |
| US2017239254A1 | United States of America | A1 | |
| AU2016238877B2 | Australia | B2 | |
| MX360495B | Mexico | B | |
| AU2018271227A1 | Australia | A1 | |
| EP3450434A1 | European Patent Office (EPO) | A1 | |
| US2019308976A1 | United States of America | A1 | |
| US2019308976A1 | United States of America | A1 | |
| MX373123B | Mexico | B | |
| AU2018271227B2 | Australia | B2 | |
| EP3450434B1 | European Patent Office (EPO) | B1 | |
| DK3450434T3 | Denmark | T3 | |
| EP3882249A1 | European Patent Office (EPO) | A1 | |
| PL3450434T3 | Poland | T3 | |
| ES2867048T3 | Spain | T3 | |
| US2021330674A1 | United States of America | A1 | |
| US2021330674A1 | United States of America | A1 | |
| US2023355629A1 | United States of America | A1 | |
| US2023355629A1 | United States of America | A1 | |
| BR122023027277A2 | Brazil | A2 | |
| CA2876306C | Canada | C | |
| US2025025467A1 | United States of America | A1 | |
| EP3882249B1 | European Patent Office (EPO) | B1 | |
| PT3882249T | Portugal | T | |
| FI3882249T3 | Finland | T3 | |
| DK3882249T3 | Denmark | T3 | |
| LT3882249T | Lithuania | T | |
| EP4606434A2 | European Patent Office (EPO) | A2 | |
| RS67061B1 | Serbia | B1 | |
| PL3882249T3This record | Poland | T3 | |
| SMT202500302T1 | San Marino | T1 | |
| ES3037872T3 | Spain | T3 | |
| HRP20250965T1 | Croatia | T1 | |
| SI3882249T1 | Slovenia | T1 |
Numbers
- Publication
- 3882249
- Application
- 21156398
Titles2
- English
- DEUTERATED DERIVATIVES OF RUXOLITINIB
- Polish
- POCHODNE DEUTEROWANE RUKSOLITYNIBU
Classification
- CPC, 11
- C07D487/04
- A61K31/519
- C07B2200/05
- A61P35/02
- A61K31/4045
- A61K31/454
- A61K31/5685
- A61K31/7068
- A61K45/06
- A61P35/00
- A61P37/02
- IPC, 4
- C07D487 04
- A61K31 519
- A61P35 02
- C07B59 00